Politician trade (House)

Zoetis (ZTS)Rep. Gilbert Cisneros (CA31) disclosed a purchase $1K–$15K

Rep. Gilbert Cisneros (CA31) disclosed a purchase of Zoetis in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
16 days
Disclosure lag
Traded
Jun 16, 2026
Disclosed
Jul 2, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Apr 14, 2026CongressDisclosed partial sale of ZTS — reported range $1,001 - $15,000
  2. Apr 21, 2026Federal contract · $627K obligatedDepartment of Agriculture awarded Zoetis: $627K obligated to date
  3. Apr 29, 20265% stakeVanguard Portfolio Management reported a passive stake (13G) of 5.7%
  4. Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.2%
  5. May 7, 2026Company filing · Form 8-K · ResultsReported its results
  6. May 8, 2026Federal contract · $484K obligatedDepartment of Agriculture awarded Zoetis: $484K obligated to date
  7. May 11, 2026Insider · 9 days before an 8-KDirector purchased ~$233K of ZTS shares in the open market
  8. May 13, 2026Insider · 2 peopleInsiders: 2 purchases (~$653K)
  9. May 20, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“Effective May 20, 2026, Ms. Louise M. Parent retired from the Board of Directors of Zoetis Inc. (the “Company”), prior to the Company’s 2026 Annual Meeting of Shareholders (the “Annual Meeting”) in accordance with the Company’s director retirement policy.”
  10. May 27, 2026Court · District Court, S.D. New YorkSecurities lawsuit filed: City of Ann Arbor Retiree Health Care Benefit Plan & Trust v. Zoetis Inc.
  11. Jun 9, 2026Congress · 1 personMembers of Congress: 2 purchases
  12. Jun 16, 2026 · this disclosureCongressDisclosed purchase of ZTS — reported range $1,001 - $15,000

What came next

  1. Jul 8, 2026Federal contract · $251 obligatedDepartment of Defense awarded Zoetis: $251 obligated to date
  2. Jul 17, 2026CongressDisclosed partial sale of ZTS — reported range $1,001 - $15,000
  3. Jul 30, 20265% stakeBlackRock, Inc. reported a passive stake (13G) of 9.0%
  4. Aug 6, 2026Company filing · Form 8-K · ResultsReported its results
  5. Aug 6, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 6, 2026, Zoetis Inc. (the “Company”) announced that James Saccaro has been appointed as Executive Vice President, Chief Financial Officer and Chief Operating Officer, effective August 17, 2026.”
  6. Aug 31, 2026Government · Federal Register noticeAuthorization of Emergency Use for Three Animal Drugs for the Prevention and Treatment of New World Screwworm; Availability
  7. Sep 14, 2026Federal contract · $35K obligatedDepartment of Health and Human Services awarded Zoetis: $35K obligated to date
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Zoetis

For Zoetis, OQRO holds 3 Congress trade reports, 53 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ZTS page.

Other recent filings by Rep. Gilbert Cisneros (CA31)

The full history of Rep. Gilbert Cisneros (CA31) is on the profile page.

How this filing works

Other disclosures at Zoetis

Everything OQRO holds on this company is on its ZTS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data